Aktieninvestor_net

Gilead Sciences überbewertet

NASDAQ:GILD   Gilead Sciences, Inc.
Auf Basis der reported EPS ist Gilead aktuell überbewertet. Trotz Earnings-Suprise

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.